Gedeon Richter Plc. operates as one of the largest pharmaceutical manufacturers in Central and Eastern Europe, distributing its products to over 100 countries worldwide. The company's business spans the entire pharmaceutical value chain, including research and development, manufacturing, wholesale, and retail distribution. Its product portfolio features over 200 medicines, highlighted by its proprietary small-molecule antipsychotic drug cariprazine and a comprehensive suite of women's healthcare products such as oral contraceptives. In addition to its legacy generic and specialty pharma business, Gedeon Richter has expanded into the biotechnology sector by developing and commercializing biosimilar products. The company maintains manufacturing facilities across multiple countries and operates an extensive sales network spanning Europe, the Americas, and Asia.
